TradingViewTradingView

Weekly Recap: Nycom acquisition and $55 million mixed consideration

阅读少于1分钟

Kewaunee Scientific Corporation (NASDAQ:KEQU) agreed to buy U.S. lab design and construction firm Nycom for $55 million, subject to EBITDA and closing adjustments. The deal is expected to close in fiscal fourth-quarter 2027.

Previous Week Recap

  • Nycom Acquisition Expected Q4: KEQU agreed on Nov. 2, 2026, to buy U.S. lab design and construction firm Nycom for $55 million, subject to EBITDA and closing adjustments. The deal is expected to close in fiscal Q4 2027. 3个来源
  • Purchase Price And Financing: Kewaunee Scientific agreed to a $55 million base purchase price, subject to adjustments. Consideration includes a subordinated note, newly issued shares, cash on hand and PNC Bank financing. PR Newswire
免责声明